
	※ 研究者情報全体を検索する場合は右端の「すべて」を選択して下さい。

1.	Inoue T, Katoh N, Ito YM, Kimura T, Nagata Y, Kuriyama K, Onishi H, Yoshitake T, Shioyama Y, Iizuka Y, Inaba K, Konishi K, Kokubo M, Karasawa K, Kozuka T, Tanaka K, Sakakibara-Konishi J, Kinoshita I, Shirato H., Stereotactic body radiotherapy to treat small lung lesions clinically diagnosed as primary lung cancer by radiological examination: A prospective observational study., Lung Cancer, 2018.08.
2.	Yoshitake T, Nakamura K, Shioyama Y, Nomoto S, Ohga S, Toba T, Shiinoki T, Anai S, Terashima H, Kishimoto J, Honda H, Breath-hold monitoring and visual feedback for radiotherapy using a charge-coupled device camera and a head-mounted display: system development and feasibility., Radiat Med, 26, 1, 50-5, 2011.07.
3.	吉武忠正, 塩山善之, 中村和正, 野元諭, 樋渡昭雄, 吉浦敬, 平田秀紀, 松本俊一, 溝口昌弘, 庄野禎久, 佐々木富男, 本田浩, 膠芽腫の放射線治療後の増悪形式とその無増悪期間、生存期間との関連について, 臨床放射線, 54, 5, 631-636, 2009.07.
4.	Yoshitake T, Shioyama Y, Nakamura K, Ohga S, Nonoshita T, Ohnishi K, Terashima K, Arimura H, Hirata H, Honda H, A clinical evaluation of visual feedback-guided breath-hold reproducibility of tumor location, Phys Med Biol, 54, 23, 7171-82, 2009.07.
5.	Yoshitake T, Nakamura K, Shioyama Y, Sasaki T, Ooga S, Abe M, Urashima Y, Urabe K, Terashima H, Honda H, Erythema multiforme and Stevens-Johnson syndrome following radiotherapy, Radiat Med, 25, 1, 27-30, 2007.07.
6.	Yoshitake T, Nakamura K, Shioyama Y, Sasaki T, Ohga S, Yamaguchi T, Toba T, Anai S, Terashima H, Honda H, A machine vision system with CCD cameras for patient positioning in radiotherapy: a preliminary report, Fukuoka Igaku Zasshi, 96, 12, 399-405, 2005.07.

1.	Tadamasa Yoshitake, Saiji Ohga, Satoshi Nomoto, Toshihiro Yamaguchi, Kaori Asai, Hidenari Hirata, Osamu Hisano, Yushi Motomura, Akio Hiwatashi, Koji Yoshimoto, Hiroshi Honda, High pre-treatment neutrophil-to-lymphocyte ratio predicts poor survival in patients with glioblastoma treated with radiotherapy and temozolomide, ASTRO2016, 2016.09.
2.	吉武忠正, Incidence of radiation pneumonitis after multiple courses of stereotactic body radiation therapy for lung cancer patients, ASTRO, 2014.09.
3.	Tadamasa Yoshitake, Yoshiyuki Shioyama, Katsumasa Nakamura, Tomonari Sasaki, Ohga Saiji, ＨｉｄｅｋｉＨｉｒａｔａ, Hiroshi Honda, Stereotactic body radiation therapy for primary lung cancers which were clinically diagnosed without pathological confirmation: a single-institution experience, RSNA, 2012.11, Purpose Pathological diagnosis of small lung lesions is sometimes difficult in inoperable patients. The purpose of the present study was to evaluate the outcome of stereotactic body radiotherapy (SBRT) for small lung lesions that are clinically diagnosed as primary lung cancer without pathologic confirmation. Materials and methods Between April 2003 and July 2011, 82 patients with small pulmonary lesions clinically diagnosed as primary lung cancer were treated with SBRT in Kyushu University Hospital. The median age of the 66 patients was 75 years (range 51- 92 years). Forty four patients were male, and 38 were female. The median tumor size was 19 mm (range 8-40 mm). Thin-section CT findings for these pulmonary lesions showed solid nodules and ground-glass opacity (GGO) nodules in 53 and 29 patients, respectively. The radiation dose was 48 Gy in 4 fractions in all patients. Results Median follow-up was 20 months (range 6-83 months). Recurrence was observed in 13 (15.9%) patients (local failure, 6; regional failure, 5; distant metastases, 6) with solid nodules. There was no recurrence in 29 patients with GGO nodules. Two patients died of recurrence and 10 patients died from other diseases. Local control rate, cause-specific survival and overall survival at 3 years were 88%, 98% and 79%, respectively. Two (2.4%) patients and 5 (6.1%) patients had grade 2 radiation pneumonitis and grade 2 rib fracturing, respectively. There were no adverse effects of grade 3 or greater during follow-up. Conclusions SBRT is to be considered a safe and effective treatment option for small lung lesions clinically diagnosed as primary lung cancer without pathologic confirmation, especially in patients with GGO nodules. .
4.	吉武忠正, 塩山善之, 大賀才路, 野々下豪, 大西かよ子, 浅井佳央里, 松本圭司, 中村和正, 平田秀紀, 本田浩 , 在宅酸素療法中の原発性肺癌患者に対する体幹部定位放射線治療, 日本放射線腫瘍学会学術大会第23回学術大会, 2010.11.
5.	Yoshitake T, Shioyama Y, Nakamura K, Ohga S, Nonoshita T, Ohnishi K, Asai K, Matsumoto K, Hirata H, Honda H., Dosimetric evaluation in stereotactic radiotherapy for pulmonary ground-glass opacity nodules: The relationship with calculation algorithm and dose prescription methods., Radiological Society of North America, 2010.12.

九大関連コンテンツ